Skip to main content
Premium Trial:

Request an Annual Quote

Incyte and Iconix Collaborate on Chemogenomic Product

NEW YORK, May 30 – Incyte Genomics and Iconix Pharmaceuticals announced on Wednesday a collaboration to develop and commercialize the next-generation of Iconix’s ChemExpress chemogenomic platform.

Incyte will exclusively market and sell ChemExpress, according to the companies. Iconix will integrate Incyte’s LifeExpress Lead databases into ChemExpress under an exclusive license from Incyte, the companies announced. Under the terms of the agreement, Incyte will make an equity investment in Iconix.

Financial terms of the collaboration and the size of the equity stake Incyte will receive were not disclosed.

The agreement will also grant Iconix a non-exclusive license to access Incyte’s LifeSeq and ZooSeq databases. Iconix will maintain exclusive rights to enter into proprietary chemogenomics collaborations with other partners, according to the companies.

“ChemExpress, incorporated with our LifeExpress Lead product, will provide drug designers a powerful information and analytical system that should accelerate target prioritization, drug candidate optimization, and predictive toxicology,” Incyte CEO Roy Whitfield said in a statement.

ChemExpress is a platform that connects genomic and biological activity data with drug molecule, pharmacology, and toxicology information. Mountain View-based Iconix also has a collaboration with Motorola using its BioChip expression array technology in the development of ChemExpress.

The Scan

Genome Sequences Reveal Range Mutations in Induced Pluripotent Stem Cells

Researchers in Nature Genetics detect somatic mutation variation across iPSCs generated from blood or skin fibroblast cell sources, along with selection for BCOR gene mutations.

Researchers Reprogram Plant Roots With Synthetic Genetic Circuit Strategy

Root gene expression was altered with the help of genetic circuits built around a series of synthetic transcriptional regulators in the Nicotiana benthamiana plant in a Science paper.

Infectious Disease Tracking Study Compares Genome Sequencing Approaches

Researchers in BMC Genomics see advantages for capture-based Illumina sequencing and amplicon-based sequencing on the Nanopore instrument, depending on the situation or samples available.

LINE-1 Linked to Premature Aging Conditions

Researchers report in Science Translational Medicine that the accumulation of LINE-1 RNA contributes to premature aging conditions and that symptoms can be improved by targeting them.